General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0DXEAS
ADC Name
CAT-03-106
Synonyms
CAT03106; CAT 03 106
   Click to Show/Hide
Organization
Catalent, Inc.
Drug Status
Investigative
Indication
In total 3 Indication(s)
Acute myeloid leukaemia
Clinical candidate
.
Hodgkin lymphoma
Clinical candidate
.
Non Hodgkin lymphoma
Clinical candidate
.
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
Undisclosed
Linker Name
Undisclosed